Pharma and Biotech Daily: Elevidys setback, Lilly's big commitment, and more!

Pharma and Biotech Daily: Elevidys setback, Lilly's big commitment, and more!

Author: Pharma and BioTech News July 28, 2025 Duration: 1:13
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. The European Medicines Agency's CHMP did not recommend approving Elevidys for ambulatory patients with Duchenne muscular dystrophy, dealing a blow to Sarepta. FDA is rumored to request new data for Elevidys, leading to uncertainty as FDA considers a new study for the drug. In other news, Eli Lilly commits $856 million to Gate Bioscience for a new class of medicines, while Rocket trims headcount and pipeline focus. Roche also drops an early obesity asset as layoffs continue in the biopharma industry, with companies like Adicet optimizing their pipelines. Novartis makes a billion-dollar drug discovery deal with Matchpoint, and the FDA opens a pilot run of the commissioner voucher program.Stay tuned for more updates on the latest developments in the pharmaceutical and biotech world.

Support the show


Every morning, the world of life sciences shifts with new clinical data, strategic deals, and regulatory decisions. Keeping pace with it all is a full-time job. Pharma and BioTech Daily is designed to be that essential, efficient briefing for professionals and investors who need the signal through the noise. This daily podcast delivers a concise, human-curated audio update that synthesizes the most critical developments from the previous day. You’ll hear clear summaries of pipeline milestones, merger and acquisition activity, policy changes, and corporate strategy shifts-all contextualized for their real-world impact. The production leverages AI tools to monitor vast data streams, but each episode is carefully supervised and narrated by editors to ensure accuracy and relevance. It’s for anyone who builds companies in this space, manages portfolios, or makes strategic decisions where science meets business. Tune in for a focused, factual, and time-saving digest that fits into your morning routine, brought to you by the team at Pharma and BioTech News and produced by the boutique studio OWITH.ai. This isn't about lengthy interviews or opinion; it's a streamlined tool to inform your day in the complex, fast-moving pharma and biotech landscape.
Author: Language: English Episodes: 236

Pharma and BioTech Daily
Podcast Episodes
**Industry Shifts: Mergers, Regulations, and Biotech Breakthroughs** [not-audio_url] [/not-audio_url]

Duration: 8:40
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of transformative events reshaping the landscape of h…
Precision Oncology and HIV Prevention Breakthroughs [not-audio_url] [/not-audio_url]

Duration: 7:37
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of fascinating advancements and strategic movements t…
Pharma Shifts: Dual-Action Obesity Drugs & Regulatory Waves [not-audio_url] [/not-audio_url]

Duration: 7:31
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today's focus is on a series of significant advancements that are poised to reshape the…
Navigating Pharma's New Frontiers: Breakthroughs and Challenges [not-audio_url] [/not-audio_url]

Duration: 6:39
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're exploring a series of significant developments that underscore the rapid e…
Gene Therapy Challenges and Regulatory Shifts: Industry Innovations [not-audio_url] [/not-audio_url]

Duration: 8:28
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a dynamic landscape of scientific breakthroughs, regulatory shifts…
Novartis' $12B RNA Therapeutics Breakthrough [not-audio_url] [/not-audio_url]

Duration: 6:17
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into some of the most significant shifts and strategies shaping our ind…
Week in Review - October 25, 2025 [not-audio_url] [/not-audio_url]

Duration: 31:24
This week in review covers 5 episodes from October 20 to October 24, featuring major developments in pharmaceutical and biotech industries including strategic acquisitions, regulatory updates, and clinical trial results.…
Pharma Innovations: AI's Impact and Strategic Shifts [not-audio_url] [/not-audio_url]

Duration: 6:34
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving deep into a series of significant events that are shaping the futur…
Strategic Acquisitions and AI Revolutionize Pharma Landscape [not-audio_url] [/not-audio_url]

Duration: 5:53
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of pivotal changes and innovations shaping the indust…